Details of the Drug

General Information of Drug (ID: DM19A89)

Drug Name
Androgen
Indication
Disease Entry ICD 11 Status REF
Hypogonadism, male N.A. Investigative [1]
Prostate cancer 2C82.0 Investigative [2]
Affected Organisms
Humans and other mammals
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H32O3
Canonical SMILES
CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
InChI
InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1
InChIKey
PDMMFKSKQVNJMI-BLQWBTBKSA-N
Cross-matching ID
PubChem CID
5995
ChEBI ID
CHEMBL1170
CAS Number
57-85-2
UNII
WI93Z9138A
DrugBank ID
DB01420
TTD ID
D0SP7S
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications. Curr Pharm Des. 2017;23(30):4475-4483.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.